A Clinical Study to evaluate effect of Gomutra Haritaki and Navak Guggulu in Medoroga (Dyslipidemia)

COMPARATIVE CLINICAL STUDY OF GOMUTRA HARITAKI AND NAVAK GUGGULU IN MEDOROGA (DYSLIPIDEMIA) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/095853

Enrollment

Registered

2025-10-09

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Medoroga (Dyslipidemia) based on lipid profile criteria Age 20 to 70 years of either gender Patients with BMI mpre than 25 kg per m Patients willing to participate in the study.

Exclusion criteria

Exclusion criteria: Patients with past history of myocardial infarction (MI), unstable angina, or stroke Patients with AIDS, cancer, tuberculosis, uncontrolled diabetes mellitus, psychiatric illness, or uncontrolled hypertension Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Improvement in Lipid Profile Parameters ( Total Cholesterol, LDL,HDL,Triglyceride, VLDL)Timepoint: Baseline,30 days and 60 days	—

Secondary

Measure	Time frame
Reduction in symptoms such as breathlessness, excessive thirst, excessive hunger, excessive sweating, and lethargyTimepoint: Baseline,30 days and 60 days	—

Countries

India

Contacts

Public ContactProf Girish KJ

Patanjali Bhartiya ayurvigyan evam anusandhan sansthan Haridwar Uttarakhand

girideepa@yahoo.co.in9448646855

Outcome results